TRENDS OF CHRONIC LIVER DISEASES IN THE UNIVERSITY HOSPITAL, UANL FOR 25 YEARS. A SINGLE-CENTER EXPERIENCE

Introduction and objectives: Liver cirrhosis is one of the main leading causes of death in Mexico. Some chronic liver diseases (CLD) are Alcoholic Liver Disease (ALD), Autoimmune Liver Disease (AILD), Hepatitis B (HBV), Hepatitis C (HCV), and Non-Alcoholic Steatohepatitis (NASH). In Mexico, ALD and...

Full description

Bibliographic Details
Main Authors: L.E. Munoz-Espinosa, C. Trevino-Garcia, I.G. Lopez-Reyna, A. Regalado-Ceballos, P. Cordero-Perez, Y.G. Alonso-Cruz, V.H. Avalos-Gómez, R. Martinez-Macias, L.A. Perez-Arredondo, R.H. Gutierrez-Carrillo, B.B. Alcocer-Galvan, L.M. Barbosa-Castillo, I.E. Hernandez-Padilla
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268121003033
_version_ 1828129459027312640
author L.E. Munoz-Espinosa
C. Trevino-Garcia
I.G. Lopez-Reyna
A. Regalado-Ceballos
P. Cordero-Perez
Y.G. Alonso-Cruz
V.H. Avalos-Gómez
R. Martinez-Macias
L.A. Perez-Arredondo
R.H. Gutierrez-Carrillo
B.B. Alcocer-Galvan
L.M. Barbosa-Castillo
I.E. Hernandez-Padilla
author_facet L.E. Munoz-Espinosa
C. Trevino-Garcia
I.G. Lopez-Reyna
A. Regalado-Ceballos
P. Cordero-Perez
Y.G. Alonso-Cruz
V.H. Avalos-Gómez
R. Martinez-Macias
L.A. Perez-Arredondo
R.H. Gutierrez-Carrillo
B.B. Alcocer-Galvan
L.M. Barbosa-Castillo
I.E. Hernandez-Padilla
author_sort L.E. Munoz-Espinosa
collection DOAJ
description Introduction and objectives: Liver cirrhosis is one of the main leading causes of death in Mexico. Some chronic liver diseases (CLD) are Alcoholic Liver Disease (ALD), Autoimmune Liver Disease (AILD), Hepatitis B (HBV), Hepatitis C (HCV), and Non-Alcoholic Steatohepatitis (NASH). In Mexico, ALD and HCV are the leading causes of CLD. Objective: To analyze the incidence of CLD in a liver unit (LU) over 25 years. Methods and materials: Clinical records of patients who attended for the first time to LU, from January 1995 to December 2019 were reviewed. There were 2780 patients with CLD, and 2668 filled the inclusion criteria with available clinical records. The diagnosis of CLD was made according to international guidelines. Inclusion criteria: patients with CLD in their first visit, with or without cirrhosis. Exclusion criteria: acute liver disease, <18 years old. Patients were divided by etiology. This study was observational, descriptive and the sampling was carried out in a non-probabilistic and convenient way. Intervals of time were group A (GA) 1995-2003, group B (GB) 2004-2011 and group C (GC) 2012-2019. A one-way ANOVA was used to determine the differences between these groups. Results: A statistically significant difference was found in the AILD, ALD and NASH groups, as determined by a one-way ANOVA (p=0.036, p=0.011 and p=<0.00). A Tukey post hoc test showed that AILD cases in GB were higher than GA (p=0.029). The same trend was observed in ALD cases, which also showed an increase between the GA and GC (p=0.012). For NASH cases, each period showed an increase (p=0.005AB, p=<0.001AC, p=0.013BC). HCV and HBV showed no statistically significant changes (Figure). Discussion: In Mexico, there is scarce information on the incidence of CLD. This study showed a higher NASH incidence (43%) than the previously reported (29%)1 as well as prevalence (23%)2 in cirrhotic patients. The incidence of HAI in this study was 17%, similar to a previous study of 16%1 in cirrhotic. Previously reported prevalence was 7.3%2 in cirrhotic patients. ALD incidence was 15%, previously reported in 23%1, and a prevalence of 31%2 in cirrhotic patients. HCV incidence had no significant changes (16%), but it was lower than previously reported (22%)1. Conclusions: This is the first study that reports an incidence of CLD in patients with or without cirrhosis. In the northeast of the country, the incidence of NASH has increased significantly during the last 25 years, becoming the most common CLD. This study found an AILD incidence similar to a previous report.1 ALD showed moderate elevation compared to NASH, and HCV began to decrease.The authors declare that there is no conflict of interest.
first_indexed 2024-04-11T16:19:13Z
format Article
id doaj.art-de3279c8dfee43cd83dcd4b624c6fbcc
institution Directory Open Access Journal
issn 1665-2681
language English
last_indexed 2024-04-11T16:19:13Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj.art-de3279c8dfee43cd83dcd4b624c6fbcc2022-12-22T04:14:25ZengElsevierAnnals of Hepatology1665-26812022-01-0127100601TRENDS OF CHRONIC LIVER DISEASES IN THE UNIVERSITY HOSPITAL, UANL FOR 25 YEARS. A SINGLE-CENTER EXPERIENCEL.E. Munoz-Espinosa0C. Trevino-Garcia1I.G. Lopez-Reyna2A. Regalado-Ceballos3P. Cordero-Perez4Y.G. Alonso-Cruz5V.H. Avalos-Gómez6R. Martinez-Macias7L.A. Perez-Arredondo8R.H. Gutierrez-Carrillo9B.B. Alcocer-Galvan10L.M. Barbosa-Castillo11I.E. Hernandez-Padilla12Liver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoLiver Unit, University Hospital “Dr. José Eleuterio González”. Monterrey, Nuevo León, MéxicoIntroduction and objectives: Liver cirrhosis is one of the main leading causes of death in Mexico. Some chronic liver diseases (CLD) are Alcoholic Liver Disease (ALD), Autoimmune Liver Disease (AILD), Hepatitis B (HBV), Hepatitis C (HCV), and Non-Alcoholic Steatohepatitis (NASH). In Mexico, ALD and HCV are the leading causes of CLD. Objective: To analyze the incidence of CLD in a liver unit (LU) over 25 years. Methods and materials: Clinical records of patients who attended for the first time to LU, from January 1995 to December 2019 were reviewed. There were 2780 patients with CLD, and 2668 filled the inclusion criteria with available clinical records. The diagnosis of CLD was made according to international guidelines. Inclusion criteria: patients with CLD in their first visit, with or without cirrhosis. Exclusion criteria: acute liver disease, <18 years old. Patients were divided by etiology. This study was observational, descriptive and the sampling was carried out in a non-probabilistic and convenient way. Intervals of time were group A (GA) 1995-2003, group B (GB) 2004-2011 and group C (GC) 2012-2019. A one-way ANOVA was used to determine the differences between these groups. Results: A statistically significant difference was found in the AILD, ALD and NASH groups, as determined by a one-way ANOVA (p=0.036, p=0.011 and p=<0.00). A Tukey post hoc test showed that AILD cases in GB were higher than GA (p=0.029). The same trend was observed in ALD cases, which also showed an increase between the GA and GC (p=0.012). For NASH cases, each period showed an increase (p=0.005AB, p=<0.001AC, p=0.013BC). HCV and HBV showed no statistically significant changes (Figure). Discussion: In Mexico, there is scarce information on the incidence of CLD. This study showed a higher NASH incidence (43%) than the previously reported (29%)1 as well as prevalence (23%)2 in cirrhotic patients. The incidence of HAI in this study was 17%, similar to a previous study of 16%1 in cirrhotic. Previously reported prevalence was 7.3%2 in cirrhotic patients. ALD incidence was 15%, previously reported in 23%1, and a prevalence of 31%2 in cirrhotic patients. HCV incidence had no significant changes (16%), but it was lower than previously reported (22%)1. Conclusions: This is the first study that reports an incidence of CLD in patients with or without cirrhosis. In the northeast of the country, the incidence of NASH has increased significantly during the last 25 years, becoming the most common CLD. This study found an AILD incidence similar to a previous report.1 ALD showed moderate elevation compared to NASH, and HCV began to decrease.The authors declare that there is no conflict of interest.http://www.sciencedirect.com/science/article/pii/S1665268121003033
spellingShingle L.E. Munoz-Espinosa
C. Trevino-Garcia
I.G. Lopez-Reyna
A. Regalado-Ceballos
P. Cordero-Perez
Y.G. Alonso-Cruz
V.H. Avalos-Gómez
R. Martinez-Macias
L.A. Perez-Arredondo
R.H. Gutierrez-Carrillo
B.B. Alcocer-Galvan
L.M. Barbosa-Castillo
I.E. Hernandez-Padilla
TRENDS OF CHRONIC LIVER DISEASES IN THE UNIVERSITY HOSPITAL, UANL FOR 25 YEARS. A SINGLE-CENTER EXPERIENCE
Annals of Hepatology
title TRENDS OF CHRONIC LIVER DISEASES IN THE UNIVERSITY HOSPITAL, UANL FOR 25 YEARS. A SINGLE-CENTER EXPERIENCE
title_full TRENDS OF CHRONIC LIVER DISEASES IN THE UNIVERSITY HOSPITAL, UANL FOR 25 YEARS. A SINGLE-CENTER EXPERIENCE
title_fullStr TRENDS OF CHRONIC LIVER DISEASES IN THE UNIVERSITY HOSPITAL, UANL FOR 25 YEARS. A SINGLE-CENTER EXPERIENCE
title_full_unstemmed TRENDS OF CHRONIC LIVER DISEASES IN THE UNIVERSITY HOSPITAL, UANL FOR 25 YEARS. A SINGLE-CENTER EXPERIENCE
title_short TRENDS OF CHRONIC LIVER DISEASES IN THE UNIVERSITY HOSPITAL, UANL FOR 25 YEARS. A SINGLE-CENTER EXPERIENCE
title_sort trends of chronic liver diseases in the university hospital uanl for 25 years a single center experience
url http://www.sciencedirect.com/science/article/pii/S1665268121003033
work_keys_str_mv AT lemunozespinosa trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT ctrevinogarcia trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT iglopezreyna trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT aregaladoceballos trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT pcorderoperez trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT ygalonsocruz trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT vhavalosgomez trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT rmartinezmacias trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT laperezarredondo trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT rhgutierrezcarrillo trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT bbalcocergalvan trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT lmbarbosacastillo trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience
AT iehernandezpadilla trendsofchronicliverdiseasesintheuniversityhospitaluanlfor25yearsasinglecenterexperience